Welcome to LookChem.com Sign In|Join Free
  • or
1-(methylsulfonyl)-4-[4-(trifluoromethoxy)phenoxy]piperidine is a chemical with a specific purpose. Lookchem provides you with multiple data and supplier information of this chemical.

287952-68-5

Post Buying Request

287952-68-5 Suppliers

Recommended suppliers

  • Product
  • FOB Price
  • Min.Order
  • Supply Ability
  • Supplier
  • Contact Supplier

287952-68-5 Usage

Chemical structure

1-(methylsulfonyl)-4-[4-(trifluoromethoxy)phenoxy]piperidine is a piperidine derivative with a methylsulfonyl group attached to the nitrogen atom and a phenyl group substituted with a trifluoromethoxy moiety.

Application

It is used in the development of pharmaceutical drugs.

Medicinal properties

It has potential medicinal properties and is being studied for its potential use as an anti-inflammatory or analgesic agent.

Pharmacological activity

The presence of the methylsulfonyl and trifluoromethoxy groups on the piperidine ring contributes to its pharmacological activity.

Drug development

It may make it a promising candidate for drug development.

Further research

Further research is needed to explore its full potential and to determine its safety and efficacy for various medical applications.

Check Digit Verification of cas no

The CAS Registry Mumber 287952-68-5 includes 9 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 6 digits, 2,8,7,9,5 and 2 respectively; the second part has 2 digits, 6 and 8 respectively.
Calculate Digit Verification of CAS Registry Number 287952-68:
(8*2)+(7*8)+(6*7)+(5*9)+(4*5)+(3*2)+(2*6)+(1*8)=205
205 % 10 = 5
So 287952-68-5 is a valid CAS Registry Number.

287952-68-5Downstream Products

287952-68-5Relevant academic research and scientific papers

Sulfamato hydroxamic acid metalloprotease inhibitor

-

, (2008/06/13)

A sulfamato hydroxamic acid compound that, inter alia, inhibits matrix metalloprotease (mmp) activity is disclosed as are a process for preparing the same, intermediate compounds useful in those syntheses, and a treatment process that comprises administering a contemplated sulfamato hydroxamic acid compound in a MMP enzyme-inhibiting effective amount to a host having a condition associated with pathological matrix metalloprotease activity.

Post a RFQ

Enter 15 to 2000 letters.Word count: 0 letters

Attach files(File Format: Jpeg, Jpg, Gif, Png, PDF, PPT, Zip, Rar,Word or Excel Maximum File Size: 3MB)

1 Customer Service

What can I do for you?
Get Best Price

Get Best Price for 287952-68-5